About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Testing Phase to Begin on New Autism Drug

by Savitha C Muppala on March 14, 2013 at 10:48 PM
 Testing Phase to Begin on New Autism Drug

A drug which claims to reverse autism is in the testing phase and will soon be verified for its efficacy, scientists have revealed.

Earlier testing has shown that the drug which is used to treat sleeping sickness is able to rectify autism like symptoms in mice.

Advertisement

The drug is known to rectify the aberrant brain connections, cell-to-cell signalling and metabolic effects which are behind this disorder.

The drug, Suramin, focuses on a cell messaging system which produces a metabolic response to stress. Scientists have discovered that the drug is capable of correcting 17 types of abnormality connected to autism.
Advertisement

Autism is a developmental disorder that typically appears during the first three years of life. It affects the brain's normal development of social and communication skills.

Autistic children are not slow learners or of a lesser IQ or suffer from mental retardation. Instead, they are very special children who have difficulty in communication and social interaction. They often come across as those who remain engrossed with restricted and repetitive behavior patterns. No two people with autism will have exactly the same symptoms. Therefore, health care providers think of autism as a 'spectrum' disorder.

Autism lasts for lifetime. There is no cure, but there are quite a few treatment options available for autistic children. Treatments include behavior and communication therapies and medicines to control symptoms. Early treatment can be beneficial to autistic children and help them lead a better life.



Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Mental Health News

Predicting PTSD Resilience Through Post Traumatic Brain Activity
Studying brain circuits tied to PTSD's progression from acute to chronic states is vital for grasping its pathophysiology and crafting targeted treatments.
High Depression Rates Among Canadian COPD Patients During COVID-19
Older adults with COPD were roughly twice as likely to develop depression if they faced functional limitations.
Comparing Suicide Risk and Depression Screenings for Identifying Patient Risk
In most scenarios, depression screening tools demonstrated superior performance compared to suicide risk screenings.
Do People With Obsessive-Compulsive Disorder Experience More Intrusive Thoughts?
Experts suggest that identifying the distinctive traits specific to obsessive-compulsive disorder can aid individuals in comprehending the mental health disorder.
Brainwave Pattern In EEG Helps Track Depression in Healthy Individuals
Electroencephalogram (EEG), which tracks the electrical activity in the brain, can help in the early identification and prevention of depression.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Testing Phase to Begin on New Autism Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests